
CHO-K1/Mouse V2 Stable Cell
Item | Cat# | Price |
Stable Cell Line | SNB-G-0227B | $19,800 |
Compound Testing Services | CT-001 | $1,850 per 384w plate (Up To 16 cpds Dose) |
Product Description
The V2 receptor (vasopressin V2 receptor) is a Gs protein-coupled receptor encoded by the AVPR2 gene, primarily distributed on the surface of renal collecting duct principal cells and vascular endothelial cells. Its core function, upon activation by arginine vasopressin, involves stimulating adenylyl cyclase via Gs protein to increase intracellular cAMP levels, thereby promoting the insertion of aquaporin-2 into the apical membrane of collecting ducts, enhancing water reabsorption to concentrate urine and maintain body water homeostasis. This receptor is the key molecule mediating antidiuretic effects; its gene mutations cause nephrogenic diabetes insipidus, and it serves as the primary target of clinical drugs (e.g., desmopressin) for treating diabetes insipidus and nocturnal enuresis.
Screeningbio’s CHO-K1/Mouse V2 cell line overexpress mouse AVPR2 and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.
Product Specifications
Target Type | GPCR |
Species | Mouse |
HGNC Symbol | AVPR2 |
Accession Number | NM_019404 (Mm) |
Parental Line | CHO-K1 |
Lot# | See Vial |
Storage | Liquid Nitrogen |
Data
![CHO-K1/Mouse V2 Agonist Assay. CHO-K1/Mouse V2 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.](https://static.wixstatic.com/media/cbf7de_567e9ecd4f4c47309a38b739fd068dc3~mv2.png/v1/fill/w_75,h_75,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/cbf7de_567e9ecd4f4c47309a38b739fd068dc3~mv2.png)
Target Background
The V2 receptor (vasopressin V2 receptor) is a Gs protein-coupled receptor encoded by the AVPR2 gene, primarily distributed on the surface of renal collecting duct principal cells and vascular endothelial cells.
Its core function, upon activation by arginine vasopressin, involves stimulating adenylyl cyclase via Gs protein to increase intracellular cAMP levels, thereby promoting the insertion of aquaporin-2 into the apical membrane of collecting ducts, enhancing water reabsorption to concentrate urine and maintain body water homeostasis.
This receptor is the key molecule mediating antidiuretic effects; its gene mutations cause nephrogenic diabetes insipidus, and it serves as the primary target of clinical drugs (e.g., desmopressin) for treating diabetes insipidus and nocturnal enuresis.
